[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100456075":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":22,"centralContacts":26,"locations":32,"responsibleParty":49,"collaborators":30,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":30,"eligibilityCriteria":57,"healthyVolunteers":53,"sex":58,"minAge":59,"maxAge":60,"enrollmentInfo":61,"targetDuration":30,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":70,"overallStatus":34,"whyStopped":30,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Children's Hospital Los Angeles","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"open label intervention arm","EXPERIMENTAL","Butyrate enemas will be administered once daily for twelve weeks.",[13],"Drug: Butyrate",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DRUG","Butyrate","Butyrate enemas will be administered once a day for 12 weeks",[9],[21],"Butyrate enemas",[23],{"name":24,"affiliation":5,"role":25},"Sonia Michail, MD","PRINCIPAL_INVESTIGATOR",[27],{"name":24,"role":28,"phone":29,"phoneExt":30,"email":31},"CONTACT","3233611353",null,"sonia.michail@hotmail.com",[33],{"facility":5,"status":34,"city":35,"state":36,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"RECRUITING","Los Angeles","California","90027","United States","US",{"type":41,"coordinates":42},"Point",[43,44],-118.24368,34.05223,{"lat":44,"lon":43},[47],{"name":24,"role":28,"phone":48,"phoneExt":30,"email":31},"(323) 361-1353",{"type":25,"investigatorFullName":24,"investigatorTitle":50,"investigatorAffiliation":5,"oldNameTitle":30,"oldOrganization":30},"Principal Investigator","100456075","phase-2-the-use-of-butyrate-therapy-in-pediatric-ulcerative-colitis-100456075",false,"NCT05218850","The Use of Butyrate Therapy in Pediatric Ulcerative Colitis","Butyrate Therapy in Hispanic Children With Ulcerative Colitis","Inclusion Criteria:\n\n* 7-21 years, mild to moderate ulcerative colitis\n\nExclusion Criteria:\n\n* UC therapy within 4 weeks of study medication initiation\n* infectious colitis, -pregnancy","ALL","7 Years","21 Years",{"count":62,"type":63},10,"ESTIMATED","INTERVENTIONAL",[66],"PHASE2","Butyrate is an important metabolite produced by the gut microbiome and has been shown as a helpful therapy in ulcerative colitis. This is a feasibility study to determine the efficacy of butryate enemas in pediatric ulcerative colitis.",[69],"Ulcerative Colitis",[71],"ulcerative colitis","2026-06-02",{"date":74,"type":75},"2026-06-04","ACTUAL",{"date":77,"type":75},"2022-06-29",{"date":79,"type":63},"2027-06-30",{"name":5,"class":6},1]